OncoSil Medical LtdASX: OSL

OncoSil TGA regulatory update

· Issued by OncoSil Medical Ltd

Filed with ASX · · 2 pages · English

Following the submission to the TGA for inclusion onto the Australian Register of Therapeutic Goods (ARTG), the Company has decided to withdraw the applicationon the basis that the provision of additional clinical data comparing the performance of the OncoSil device directly with other standard therapies is expected to support the application. Nigel Lange, CEO of OncoSil Medical, commented: We app

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases